Diagnostic Ultrasound - Abdomen and Pelvis
Pheochromocytoma TERMINOLOGY Definitions • Paraganglioma: Neuroendocrine tumor arising from paraganglia anywhere in sympathetic chain • Pheochromocytoma: Adrenal medullary paraganglioma ○ Arises from catecholamine-secreting chromaffin cells of adrenal medulla IMAGING General Features • Best diagnostic clue ○ Adrenal mass in setting of clinical symptoms or biochemical abnormality • Location ○ Paragangliomas occur along sympathetic chain: Neck to urinary bladder ○ Majority are subdiaphragmatic (98%) – Adrenal (90%); extraadrenal (10%) □ Aortic bifurcation: Organ of Zuckerkandl, 2.5% ○ Typically unilateral ○ Bilateral: Commonly with hereditary conditions; 10% of sporadic cases • Size ○ Variable: Up to 15 cm (typically 3-5 cm) • Morphology ○ Well-circumscribed, encapsulated tumor ○ Variable size & appearance, "chameleon tumors" – Commonly solid and hypervascular ± cystic change, necrosis, and calcification – Can be purely cystic ○ Pheochromocytomas and paragangliomas demonstrate similar imaging features but vary in location Ultrasonographic Findings • Grayscale ultrasound ○ Variable appearance: Solid (75%) > solid/cystic or cystic – Iso-/hypoechoic (77%) or hyperechoic (23%) to kidney ○ Small tumors: Solid, well-circumscribed; uniform echoes ○ Large tumors: Solid; homogeneous (46%) or heterogeneous (54%) echo pattern – Complex echo pattern: Necrosis (hypoechoic) &/or hemorrhage (hyperechoic) ○ Can be predominantly cystic lesions due to chronic hemorrhage and necrotic debris (fluid-fluid level) ○ Overlying bowel gas can obscure extraadrenal masses ○ Always evaluate bladder wall, renal hilum, and organ of Zuckerkandl at origin of inferior mesenteric artery • Color Doppler ○ Hypervascular ○ Compression/invasion of IVC/renal vein – Seen with both benign & malignant tumors CT Findings • NECT: Well-defined mass with low soft tissue attenuation ○ Generally attenuation > 10 HU; however, rarely intracellular fat may result in lower attenuation ○ ±: ↑ density (hemorrhage), ↓ density (cystic degeneration; necrosis), calcification (rare; 10%) • CECT: Marked enhancement; may be heterogeneous due to hemorrhage/necrosis ○ Variable washout characteristics: Can show rapid washout that mimics adenoma ○ No convincing evidence that IV injection of iodinated contrast precipitates hypertensive crisis (previous belief) MR Findings • T1WI: Isointense to muscle & hypointense to liver ○ Variable signal intensity if necrosis/hemorrhage present ○ If microscopic fat present (rare), chemical shift signal loss may mimic adenoma • T2WI: T2 hyperintense due to ↑ water content (cystic/liquefactive necrosis) ○ Classic "light-bulb" appearance of marked T2-bright SI, variably seen (11-65%) ○ 35% have low T2 SI (isointense to spleen) ○ Most common: heterogeneously enhancing lesion with multiple high-SI pockets • T1WI C+: Characteristic "salt and pepper" pattern ○ Salt (enhancing parenchyma); pepper (↑ vascular flow voids due to hypervascular tumor) Nuclear Medicine Findings • First-line: I-123 metaiodobenzylguanidine (MIBG) ○ Norepinephrine analog ○ After 24-72 hours: ↑ uptake of I-123 MIBG in tumor ○ Useful for extraadrenal, metastatic, recurrent disease ○ Sensitivity (79-88%); specificity (~ 100%) • 2nd line: In-111 Pentetreotide, FDG PET, DOPA analogs Imaging Recommendations • Best imaging tool ○ US: Comparable sensitivity to CT for detection of adrenal disease; poor detection of extraadrenal tumors ○ NE + CECT: Overall 93-100% sensitive; however, up to 40% extraadrenal lesions may be missed on CT ○ I-123 MIBG: Superior detection of extraadrenal, metastatic, &/or recurrent disease • Protocol advice ○ Include aortic bifurcation in CT/MR field of view to evaluate for paragangliomas DIFFERENTIAL DIAGNOSIS Adrenal Adenoma • Most common adrenal lesion; benign • Pheochromocytomas tend to be larger than adenomas • Cystic and rare microscopic fat-containing pheochromocytomas may also be hypodense on NECT • Adenoma: Characteristic CT washout & MR signal dropout Adrenal Metastases • Most common malignant adrenal neoplasm (27% of all cancer) • Typically bilateral; delayed contrast washout Adrenal Lymphoma • Large infiltrative, bilateral masses; adrenals maintain shape • 25% secondary to non-Hodgkin lymphoma; primary is rare Diagnoses: Adrenal Gland 599
Pheochromocytoma 600 Diagnoses: Adrenal Gland Adrenocortical Carcinoma • Rare; aggressive; large, unilateral, heterogeneous solid with necrosis; hemorrhage ± calcification • ↑ T1 and ↓ T2 signal (as with "classic" pheochromocytomas) • Aggressive, often with IVC extension Adrenal Neuroblastoma • Large pediatric adrenal mass; calcification (80-90%) Adrenal Granulomatous Infection • TB, histoplasmosis, other fungal diseases; usually bilateral ○ Acute (hypoechoic masses) or chronic (small & calcified) PATHOLOGY General Features • Associated abnormalities ○ Majority are sporadic ○ 25% have autosomal dominant gene mutation – Multiple endocrine neoplasia, type II (MEN2) □ MEN2 mutation; 50% have pheochromocytoma □ Medullary thyroid carcinoma; hyperparathyroidism; neuromas and marfanoid habitus – von Hippel-Lindau (VHL) disease □ VHL tumor suppressor gene, 10-20% risk □ Multiple benign and malignant tumors – Neurofibromatosis, type I □ Rare cause of pheochromocytomas (1% risk) □ Cutaneous/plexiform neurofibromas, optic nerve gliomas, peripheral nerve sheath tumors, gastrointestinal stromal tumor – Pheochromocytoma-paraganglioma syndromes □ Mutations of succinate dehydrogenase gene family (SDHB and SDHD) □ ↑ incidence of extraadrenal tumors and head/neck paragangliomas □ 50% risk of malignant pheochromocytomas • Most are benign; 10% are malignant ○ Diagnosis of malignancy is based solely on presence of direct local tumor invasion or metastatic disease ○ Extraadrenal paragangliomas are more likely to be malignant Gross Pathologic & Surgical Features • Range of appearances: Small, well-circumscribed, yellowtan lesion confined to adrenals; large, hemorrhagic, cysticnecrotic masses Microscopic Features • Predominantly chromaffin cells; occasionally spindle cells are dominant feature ○ Term pheochromocytoma refers to dusky color of cells stained with chromium salts • No single histologic feature of pheochromocytoma consistently predicts malignancy CLINICAL ISSUES Presentation • Most common signs/symptoms ○ Majority are asymptomatic; symptoms may be episodic or paroxysmal ○ Classic triad (arises from adrenergic excess) – Paroxysmal headache, palpitations, sweating – 90% specific but uncommon (only present in 10.0- 36.5% of patients) • Other signs/symptoms ○ Hypertensive crisis: Palpitations, tremors, arrhythmias, pain, myocardial infarction • Lab data ○ Tumors typically secrete norepinephrine > epinephrine ○ ↑ levels of 24-hour urine-fractionated metanephrines – 90-97% sensitivity; 69-98% specificity Demographics • Age ○ Sporadic cases, 3rd and 4th decades (mean age: 44 years) ○ Hereditary cases (mean age: 25 years) ○ 10% are found in children • Gender ○ Slight female predilection (M:F = 1:1.4) • Epidemiology ○ Incidence (exact unknown): Estimated at 2-8 cases/1 million people/year – 0.1-0.6% of hypertensive adults ○ Majority of pheochromocytomas are likely asymptomatic (incidentalomas) – Autopsy occurrence rates 10-17% Natural History & Prognosis • Hypertensive crises and cardiovascular complications ↑ morbidity/mortality • Prognosis ○ Noninvasive and nonmetastatic: Typically favorable – Postoperatively: 50% have persistent hypertension; 16% recur within 10 years of resection ○ Malignant tumors: 54% 5-year survival rate Treatment • Symptomatic therapy: α-adrenergic blockade and calcium channel antagonists • Laparoscopic resection/debulking for both benign and malignant tumors • Adjuvant therapy (malignant tumors): I-131 MIBG therapy ± chemotherapy (cyclophosphamide, vincristine, dacarbazine) DIAGNOSTIC CHECKLIST Consider • Imaging characteristics can mimic other diagnoses; labs essential for diagnosis Image Interpretation Pearls • Extraadrenal tumors arise anywhere along sympathetic ganglia (neck to bladder); include in search pattern SELECTED REFERENCES 1. Lattin GE Jr et al: From the radiologic pathology archives: adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation. Radiographics. 34(3):805-29, 2014 2. Leung K et al: Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging. AJR Am J Roentgenol. 200(2):370-8, 2013 3. Raja A et al: Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors. AJR Am J Roentgenol. 201(4):825-33, 2013
- Page 570 and 571: Schistosomiasis, Bladder TERMINOLOG
- Page 572 and 573: PART II SECTION 6 Kidney Transplant
- Page 574 and 575: Approach to Sonography of Renal All
- Page 576 and 577: Approach to Sonography of Renal All
- Page 578 and 579: Approach to Sonography of Renal All
- Page 580 and 581: Allograft Hydronephrosis TERMINOLOG
- Page 582 and 583: Allograft Hydronephrosis (Left) Lon
- Page 584 and 585: Perigraft Fluid Collections TERMINO
- Page 586 and 587: Perigraft Fluid Collections (Left)
- Page 588 and 589: Transplant Renal Artery Stenosis TE
- Page 590 and 591: Transplant Renal Artery Stenosis (L
- Page 592 and 593: Transplant Renal Artery Thrombosis
- Page 594 and 595: Transplant Renal Vein Thrombosis TE
- Page 596 and 597: Renal Transplant Arteriovenous (AV)
- Page 598 and 599: Renal Transplant Pseudoaneurysm TER
- Page 600 and 601: Renal Transplant Rejection IMAGING
- Page 602 and 603: Delayed Renal Graft Function TERMIN
- Page 604 and 605: PART II SECTION 7 Adrenal Gland Adr
- Page 606 and 607: Adrenal Hemorrhage TERMINOLOGY Abbr
- Page 608 and 609: Adrenal Hemorrhage (Left) Longitudi
- Page 610 and 611: Myelolipoma TERMINOLOGY Definitions
- Page 612 and 613: Myelolipoma (Left) Longitudinal US
- Page 614 and 615: Adrenal Adenoma TERMINOLOGY Synonym
- Page 616 and 617: Adrenal Adenoma (Left) Longitudinal
- Page 618 and 619: Adrenal Cyst TERMINOLOGY Definition
- Page 622 and 623: Pheochromocytoma (Left) Longitudina
- Page 624 and 625: Adrenal Carcinoma TERMINOLOGY Synon
- Page 626 and 627: Adrenal Carcinoma (Left) Transverse
- Page 628 and 629: PART II SECTION 8 Abdominal Wall/Pe
- Page 630 and 631: Approach to Sonography of Abdominal
- Page 632 and 633: Approach to Sonography of Abdominal
- Page 634 and 635: Abdominal Wall Hernia TERMINOLOGY D
- Page 636 and 637: Abdominal Wall Hernia (Left) Transv
- Page 638 and 639: Abdominal Wall Hernia (Left) Transv
- Page 640 and 641: Groin Hernia TERMINOLOGY Definition
- Page 642 and 643: Groin Hernia (Left) Graphic shows a
- Page 644 and 645: Groin Hernia (Left) Longitudinal ul
- Page 646 and 647: Ascites TERMINOLOGY Definitions •
- Page 648 and 649: Ascites (Left) Transverse ultrasoun
- Page 650 and 651: Peritoneal Carcinomatosis TERMINOLO
- Page 652 and 653: Peritoneal Carcinomatosis (Left) Lo
- Page 654 and 655: Peritoneal Carcinomatosis (Left) Tr
- Page 656 and 657: Peritoneal Space Abscess TERMINOLOG
- Page 658 and 659: Peritoneal Space Abscess (Left) Tra
- Page 660 and 661: Segmental Omental Infarction TERMIN
- Page 662 and 663: PART II SECTION 9 Bowel Approach to
- Page 664 and 665: Approach to Bowel Sonography Given
- Page 666 and 667: Approach to Bowel Sonography (Left)
- Page 668 and 669: Appendicitis TERMINOLOGY Definition
Pheochromocytoma<br />
TERMINOLOGY<br />
Definitions<br />
• Paraganglioma: Neuroendocrine tumor arising from<br />
paraganglia anywhere in sympathetic chain<br />
• Pheochromocytoma: Adrenal medullary paraganglioma<br />
○ Arises from catecholamine-secreting chromaffin cells of<br />
adrenal medulla<br />
IMAGING<br />
General Features<br />
• Best diagnostic clue<br />
○ Adrenal mass in setting of clinical symptoms or<br />
biochemical abnormality<br />
• Location<br />
○ Paragangliomas occur along sympathetic chain: Neck to<br />
urinary bladder<br />
○ Majority are subdiaphragmatic (98%)<br />
– Adrenal (90%); extraadrenal (10%)<br />
□ Aortic bifurcation: Organ of Zuckerk<strong>and</strong>l, 2.5%<br />
○ Typically unilateral<br />
○ Bilateral: Commonly with hereditary conditions; 10% of<br />
sporadic cases<br />
• Size<br />
○ Variable: Up to 15 cm (typically 3-5 cm)<br />
• Morphology<br />
○ Well-circumscribed, encapsulated tumor<br />
○ Variable size & appearance, "chameleon tumors"<br />
– Commonly solid <strong>and</strong> hypervascular ± cystic change,<br />
necrosis, <strong>and</strong> calcification<br />
– Can be purely cystic<br />
○ Pheochromocytomas <strong>and</strong> paragangliomas demonstrate<br />
similar imaging features but vary in location<br />
Ultrasonographic Findings<br />
• Grayscale ultrasound<br />
○ Variable appearance: Solid (75%) > solid/cystic or cystic<br />
– Iso-/hypoechoic (77%) or hyperechoic (23%) to kidney<br />
○ Small tumors: Solid, well-circumscribed; uniform echoes<br />
○ Large tumors: Solid; homogeneous (46%) or<br />
heterogeneous (54%) echo pattern<br />
– Complex echo pattern: Necrosis (hypoechoic) &/or<br />
hemorrhage (hyperechoic)<br />
○ Can be predominantly cystic lesions due to chronic<br />
hemorrhage <strong>and</strong> necrotic debris (fluid-fluid level)<br />
○ Overlying bowel gas can obscure extraadrenal masses<br />
○ Always evaluate bladder wall, renal hilum, <strong>and</strong> organ of<br />
Zuckerk<strong>and</strong>l at origin of inferior mesenteric artery<br />
• Color Doppler<br />
○ Hypervascular<br />
○ Compression/invasion of IVC/renal vein<br />
– Seen with both benign & malignant tumors<br />
CT Findings<br />
• NECT: Well-defined mass with low soft tissue attenuation<br />
○ Generally attenuation > 10 HU; however, rarely<br />
intracellular fat may result in lower attenuation<br />
○ ±: ↑ density (hemorrhage), ↓ density (cystic<br />
degeneration; necrosis), calcification (rare; 10%)<br />
• CECT: Marked enhancement; may be heterogeneous due<br />
to hemorrhage/necrosis<br />
○ Variable washout characteristics: Can show rapid<br />
washout that mimics adenoma<br />
○ No convincing evidence that IV injection of iodinated<br />
contrast precipitates hypertensive crisis (previous belief)<br />
MR Findings<br />
• T1WI: Isointense to muscle & hypointense to liver<br />
○ Variable signal intensity if necrosis/hemorrhage present<br />
○ If microscopic fat present (rare), chemical shift signal loss<br />
may mimic adenoma<br />
• T2WI: T2 hyperintense due to ↑ water content<br />
(cystic/liquefactive necrosis)<br />
○ Classic "light-bulb" appearance of marked T2-bright SI,<br />
variably seen (11-65%)<br />
○ 35% have low T2 SI (isointense to spleen)<br />
○ Most common: heterogeneously enhancing lesion with<br />
multiple high-SI pockets<br />
• T1WI C+: Characteristic "salt <strong>and</strong> pepper" pattern<br />
○ Salt (enhancing parenchyma); pepper (↑ vascular flow<br />
voids due to hypervascular tumor)<br />
Nuclear Medicine Findings<br />
• First-line: I-123 metaiodobenzylguanidine (MIBG)<br />
○ Norepinephrine analog<br />
○ After 24-72 hours: ↑ uptake of I-123 MIBG in tumor<br />
○ Useful for extraadrenal, metastatic, recurrent disease<br />
○ Sensitivity (79-88%); specificity (~ 100%)<br />
• 2nd line: In-111 Pentetreotide, FDG PET, DOPA analogs<br />
Imaging Recommendations<br />
• Best imaging tool<br />
○ US: Comparable sensitivity to CT for detection of adrenal<br />
disease; poor detection of extraadrenal tumors<br />
○ NE + CECT: Overall 93-100% sensitive; however, up to<br />
40% extraadrenal lesions may be missed on CT<br />
○ I-123 MIBG: Superior detection of extraadrenal,<br />
metastatic, &/or recurrent disease<br />
• Protocol advice<br />
○ Include aortic bifurcation in CT/MR field of view to<br />
evaluate for paragangliomas<br />
DIFFERENTIAL DIAGNOSIS<br />
Adrenal Adenoma<br />
• Most common adrenal lesion; benign<br />
• Pheochromocytomas tend to be larger than adenomas<br />
• Cystic <strong>and</strong> rare microscopic fat-containing<br />
pheochromocytomas may also be hypodense on NECT<br />
• Adenoma: Characteristic CT washout & MR signal dropout<br />
Adrenal Metastases<br />
• Most common malignant adrenal neoplasm (27% of all<br />
cancer)<br />
• Typically bilateral; delayed contrast washout<br />
Adrenal Lymphoma<br />
• Large infiltrative, bilateral masses; adrenals maintain shape<br />
• 25% secondary to non-Hodgkin lymphoma; primary is rare<br />
Diagnoses: Adrenal Gl<strong>and</strong><br />
599